1/22
Flashcards cover key signaling pathways and mechanisms from GPCR, RTK, NO-cGMP, Wnt/β-catenin, NF-κB, and RhoA/ROCK, as described in the lecture notes.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
In this patient with melanoma and a V600E BRAF mutation treated with Vemurafenib, the drug's mechanism is __.
Inhibiting the activity of the V600E variant of BRAF.
Mutations in BRAF are found in _% of melanoma.
40-60%
Ligand for RTK
GF, mem bound organelles
Adaptor proteins such as Grb2 and SOS activated by phosphorylated RTK facilitate the activation of , a small GTP-binding protein.
RAS
Ras signal cascade
RTK, RAS, RAF, MEK, ERK
RAF kinases phosphorylate and activate , which then phosphorylates ERK.
MEK
Activated ERK phosphorylates transcription factors such as .
Ets, Fos, Elk1, and MYC
The first membrane signaling step in GPCR Gq signaling is activation of , which hydrolyzes PIP2 into DAG and IP3.
phospholipase C-β (PLC-β)
IP3 triggers Ca²⁺ release and, together with DAG, activates .
protein kinase C (PKC)
Protein regulating Grb2, SOS
NF1
Cholera toxin ADP-ribosylates the Gsα subunit, locking it in the active GTP state and constitutively activating .
adenylate cyclase
Cholera toxin mechanism differs from Gq signaling because Gq activates PLC to make IP3/DAG, while Gs activates to raise cAMP.
adenylate cyclase (cAMP production)
NO is synthesized by endothelial NOS (eNOS) from the amino acid .
arginine
NO activates soluble guanylate cyclase to produce the second messenger , which activates PKG.
cGMP
In atherosclerosis, reduced NO bioavailability leads to diminished cGMP production and decreased signaling via .
cGMP-PKG signaling
In the canonical Wnt pathway, the OFF state keeps β-catenin by the destruction complex.
degraded
In the ON state of Wnt signaling, stabilized β-catenin accumulates and translocates to the nucleus to interact with to activate transcription.
TCF
Wnt signaling drives Myc activation via transcription.
β-catenin/TCF-mediated
The best etiology for acromegaly is that the pituitary adenoma causes increased release of growth hormone, resulting in elevated .
IGF-1
Activation of α1‑adrenergic receptors signals via to produce IP3 and DAG, leading to Ca²⁺ release and PKC activation.
phospholipase C (PLC)
β-adrenergic receptors are Gs-coupled GPCRs; their activation increases , which in turn activates PKA.
cAMP
NF-κB activation via the canonical pathway involves cytokines triggering the IKK complex to phosphorylate IκB, leading to its degradation and the release of NF-κB that translocates to the nucleus to .
drive transcription of NF-κB–dependent genes
RhoA-GTP activates ROCK, which inhibits phosphatase, increasing MLC phosphorylation and smooth muscle contraction.
myosin light chain phosphatase (MLCP)